Results
TRD
A total of 1148 adult patients with TRD were enrolled into SUSTAIN-3. Overall, 458 participants were enrolled into the induction phase, 38 (8.3%) of whom discontinued and 420 (91.7%) continued to the optimization/maintenance phase. In addition, 690 other participants were enrolled directly into the optimization/maintenance phase (Fig. 